ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronEye IconIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintSite TitleTitle ChevronIcon Twitter
Politics

Russia trying to steal COVID-19 vaccine data, say UK, US, Canada

Western nations condemn hackers 'almost certainly' working for Moscow

U.K., U.S. and Canadian authorities say a Russian hacker group nicknamed "Cozy Bear" is targeting COVID-19 vaccine research data at Western drug companies and research agencies.   © Reuters

LONDON/OTTAWA (Reuters) -- Hackers backed by the Russian state are trying to steal COVID-19 vaccine and treatment research from academic and pharmaceutical institutions around the world, Britain's National Cyber Security Centre (NCSC) said on Thursday.

A co-ordinated statement from Britain, the United States and Canada attributed the attacks to group APT29, also known as Cozy Bear, which they said was almost certainly operating as part of Russian intelligence services.

"We condemn these despicable attacks against those doing vital work to combat the coronavirus pandemic," said NCSC Director of Operations Paul Chichester.

Cybersecurity researchers said an APT29 hacking tool was used against clients located in United States, Japan, China and Africa over the last year.

Russian news agency RIA cited spokesman Dmitry Peskov as saying the Kremlin rejected London's allegations, which he said were not backed by proper evidence.

In a separate announcement Britain also accused "Russian actors" of trying to interfere in its 2019 election by trying to spread leaked documents online. Russia's foreign ministry said those accusations were "foggy and contradictory".

Britain is expected to publish a long-delayed report into Russian influence in British politics next week.

British foreign minister Dominic Raab said it was "completely unacceptable" for Russian intelligence services to target work on the pandemic.

"While others pursue their selfish interests with reckless behaviour, the UK and its allies are getting on with the hard work of finding a vaccine and protecting global health," he said in a statement. He said Britain would work with allies to hold perpetrators to account.

The NCSC said the group's attacks were continuing and used a variety of tools and techniques, including spear-phishing and custom malware.

"APT29 is likely to continue to target organisations involved in COVID-19 vaccine research and development, as they seek to answer additional intelligence questions relating to the pandemic," the NCSC statement said.

The U.S. Department of Homeland Security and U.S. Cyber Command also released technical information on Thursday about three hacking tools being deployed by the Russian hackers, codenamed WELLMAIL, SOREFANG and WELLMESS.

Private sector cybersecurity researchers who had spotted the WELLMESS malware over the last year were unaware of its Russian origins until Thursday.

In several cases, WELLMESS was found within U.S. pharmaceutical companies, said three investigators familiar with the matter, who spoke on condition of anonymity to discuss confidential information. The tool allowed the hackers to stealthily gain remote access to secure computers. They declined to name the victims.

Britain and the United States said in May that networks of hackers were targeting national and international organisations responding to the pandemic. But such attacks have not previously been explicitly connected to the Russian state.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this monthThis is your last free article this month

Stay ahead with our exclusives on Asia;
the most dynamic market in the world.

Stay ahead with our exclusives on Asia

Get trusted insights from experts within Asia itself.

Get trusted insights from experts
within Asia itself.

Try 1 month for $0.99

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this month

This is your last free article this month

Stay ahead with our exclusives on Asia; the most
dynamic market in the world
.

Get trusted insights from experts
within Asia itself.

Try 3 months for $9

Offer ends July 31st

Your trial period has expired

You need a subscription to...

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers and subscribe

Your full access to the Nikkei Asian Review has expired

You need a subscription to:

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers
NAR on print phone, device, and tablet media